ES8704900A1 - Un procedimiento para preparar una sal de quelato con piridina - Google Patents
Un procedimiento para preparar una sal de quelato con piridinaInfo
- Publication number
- ES8704900A1 ES8704900A1 ES552072A ES552072A ES8704900A1 ES 8704900 A1 ES8704900 A1 ES 8704900A1 ES 552072 A ES552072 A ES 552072A ES 552072 A ES552072 A ES 552072A ES 8704900 A1 ES8704900 A1 ES 8704900A1
- Authority
- ES
- Spain
- Prior art keywords
- radionuclide
- dihydropyridine
- brain
- site
- pyridinium salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63231484A | 1984-07-19 | 1984-07-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8704900A1 true ES8704900A1 (es) | 1987-04-16 |
| ES552072A0 ES552072A0 (es) | 1987-04-16 |
Family
ID=24535023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES552072A Expired ES8704900A1 (es) | 1984-07-19 | 1986-02-17 | Un procedimiento para preparar una sal de quelato con piridina |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0187832A1 (da) |
| JP (1) | JPS61106556A (da) |
| KR (1) | KR900007514B1 (da) |
| AU (1) | AU4635885A (da) |
| CA (1) | CA1267899A (da) |
| DK (1) | DK124786A (da) |
| ES (1) | ES8704900A1 (da) |
| FI (1) | FI861118A0 (da) |
| GR (1) | GR851792B (da) |
| NO (1) | NO860981L (da) |
| PT (1) | PT80841B (da) |
| WO (1) | WO1986000898A1 (da) |
| ZA (1) | ZA855476B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4888427A (en) * | 1987-04-07 | 1989-12-19 | University Of Florida | Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain |
| US5079366A (en) * | 1987-04-07 | 1992-01-07 | University Of Florida | Quarternary pyridinium salts |
| EP0301751B1 (en) * | 1987-07-31 | 1993-03-10 | Takeda Chemical Industries, Ltd. | Pyridinium derivatives, their production and use |
| DE4107570A1 (de) * | 1991-03-07 | 1992-11-19 | Diagnostikforschung Inst | Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie |
| JP4677863B2 (ja) * | 2005-09-05 | 2011-04-27 | 堺化学工業株式会社 | チオール系光硬化性モノマーおよび光硬化型樹脂組成物 |
| US8701166B2 (en) | 2011-12-09 | 2014-04-15 | Blackberry Limited | Secure authentication |
| US10864279B2 (en) * | 2016-12-16 | 2020-12-15 | Industrial Technology Research Institute | Linker-drug and antibody-drug conjugate (ADC) employing the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1983003968A1 (en) * | 1982-05-18 | 1983-11-24 | University Of Florida | Brain-specific drug delivery |
-
1985
- 1985-07-15 WO PCT/US1985/001334 patent/WO1986000898A1/en not_active Application Discontinuation
- 1985-07-15 AU AU46358/85A patent/AU4635885A/en not_active Abandoned
- 1985-07-15 EP EP85903633A patent/EP0187832A1/en not_active Withdrawn
- 1985-07-18 KR KR1019850005137A patent/KR900007514B1/ko not_active IP Right Cessation
- 1985-07-18 GR GR851792A patent/GR851792B/el unknown
- 1985-07-19 JP JP60160040A patent/JPS61106556A/ja active Pending
- 1985-07-19 CA CA000487165A patent/CA1267899A/en not_active Expired - Fee Related
- 1985-07-19 ZA ZA855476A patent/ZA855476B/xx unknown
- 1985-07-19 PT PT80841A patent/PT80841B/pt unknown
-
1986
- 1986-02-17 ES ES552072A patent/ES8704900A1/es not_active Expired
- 1986-03-14 NO NO860981A patent/NO860981L/no unknown
- 1986-03-18 FI FI861118A patent/FI861118A0/fi not_active Application Discontinuation
- 1986-03-18 DK DK124786A patent/DK124786A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GR851792B (da) | 1985-11-26 |
| FI861118A (fi) | 1986-03-18 |
| KR900007514B1 (ko) | 1990-10-11 |
| FI861118A0 (fi) | 1986-03-18 |
| EP0187832A1 (en) | 1986-07-23 |
| DK124786A (da) | 1986-05-20 |
| AU4635885A (en) | 1986-02-25 |
| PT80841A (en) | 1985-08-01 |
| ZA855476B (en) | 1987-03-25 |
| KR860000871A (ko) | 1986-02-20 |
| PT80841B (en) | 1987-06-03 |
| CA1267899A (en) | 1990-04-17 |
| ES552072A0 (es) | 1987-04-16 |
| JPS61106556A (ja) | 1986-05-24 |
| NO860981L (no) | 1986-05-20 |
| DK124786D0 (da) | 1986-03-18 |
| WO1986000898A1 (en) | 1986-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5679318A (en) | Stable therapeutic radionuclide compositions and methods for preparation thereof | |
| US5393512A (en) | Stable therapeutic radionuclide compositions and methods for preparation thereof | |
| ZA906634B (en) | Chelating agent for forming complexes with radioactive isotopes,metal complexes thereof and use thereof in diagnosis and therepy | |
| NZ221932A (en) | Amide complexing agent and radiographic compositions | |
| KR840002645A (ko) | 안정된 방사성 진단제와 이를 위한 비방사성 캐리어 | |
| GB1508900A (en) | Technetium 99-m labelled radio-diagnostic agents non radioactive carriers therefor and method of preparation thereo | |
| KR960010683A (ko) | 소마토스타틴 펩타이드, 이의 제법 및 이를 함유하는 약학적 조성물 | |
| ES8704900A1 (es) | Un procedimiento para preparar una sal de quelato con piridina | |
| US4645660A (en) | Increasing labeling efficiency by forming diagnostic agent in the presence of ascorbic acid or the like | |
| ATE179076T1 (de) | Chelatbildner vom typ xn 1?s 1?o 1? für radioaktive isotope, deren metallkomplexe und ihre verwendung in diagnostik und therapie | |
| IE882607L (en) | Method of labeling substances with technetium or rhenium | |
| JPS5750928A (en) | Diagnostic agent for scanning bone | |
| CA1324317C (en) | Stable radiodiagnostic products, and the preparation thereof | |
| KR930700163A (ko) | 연조직 종양의 치료 및/또는 진단 방법 | |
| PH12274A (en) | 6-chloro 2(1'-piperazinyl)pyrazine compound,pharmaceutical composition and method of use thereof | |
| AU2288988A (en) | Boronic acid adducts of rhenium and radioactive isotopes of rhenium dioxime complexes | |
| ES8700236A1 (es) | Un procedimiento para preparar una sal de quelato con hete- rociclo nitrogenado | |
| GB2156345B (en) | Alkylamine salts of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents | |
| GB1404252A (en) | 99m-technetium labelled tin colloid radiopharmaceuticals | |
| GB1273446A (en) | Chelated radioisotope solutions | |
| GB1564420A (en) | Technetium-99m-labelled diagnostic agent for kidney scanning and process for its manufacture | |
| EP0493526A1 (en) | Stable therapeutic radionuclide compositions and methods for preparation thereof | |
| Özker et al. | 99m Tc-gentamicin: Chemical and biological evaluation | |
| Ballinger et al. | Stabilization of 99m Tc-pyrophosphate injection with gentisic acid | |
| Srivastava et al. | Recent developments in blood cell labeling research |